Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance

BACKGROUND/AIMS: The novel prokinetic drug acotiamide is used for treatment of functional dyspepsia. It is still unclear how acotiamide has effects on esophageal motor function. Esophageal peristalsis and esophagogastric junction (EGJ) compliance has an important role for prevention of esophageal mu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neurogastroenterol Motil
Autori principali: Mikami, Hironobu, Ishimura, Norihisa, Okada, Mayumi, Izumi, Daisuke, Okimoto, Eiko, Ishihara, Shunji, Kinoshita, Yoshikazu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Society of Neurogastroenterology and Motility 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885723/
https://ncbi.nlm.nih.gov/pubmed/29605979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm16111
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi